Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest

22 Nov, 2018, 07:00 GMT FDA Grants Priority Review for Daiichi Sankyo's New Drug Application for FLT3 Inhibitor Quizartinib for Treatment of Patients with Relapsed/Refractory FLT3-ITD AML

Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced that the U.S. Food and Drug Administration (FDA) has accepted a New Drug...


21 Nov, 2018, 15:00 GMT Blueberry Therapeutics Limited Announce Positive Results from a Phase I/II Clinical Trial

Blueberry Therapeutics Limited ("Blueberry Therapeutics"), a modern drug discovery and development company committed to the development of innovative ...


20 Nov, 2018, 17:53 GMT Pilatus Comparator Solutions US Expansion

PCS Inc. Long Island US Facility fully licenced and operational As part of Pilatus Comparator Solutions' ongoing plans to strengthen its Global...


20 Nov, 2018, 08:00 GMT Asceneuron Initiates Neuroimaging Trial for Tau Modifier ASN120290

Major milestone in development of novel treatment for progressive supranuclear palsy and other tau-related dementias Asceneuron SA, an emerging...


15 Nov, 2018, 07:00 GMT Arix Bioscience plc: Pharmaxis Releases Positive Results of Phase 1 Clinical Trial for Second LOXL2 Inhibitor Compound

Arix Bioscience plc ("Arix") (LSE: ARIX), a global healthcare and life science company supporting medical innovation, is pleased to note that...


14 Nov, 2018, 13:00 GMT Dragonfly Therapeutics Announces Expansion of its Strategic Collaboration with Celgene, Doubling the Number of Programs and Including Targets for Solid Tumor Indications

Dragonfly Therapeutics, Inc. ("Dragonfly" or the "Company"), today announced it entered into a new agreement with Celgene Corporation and its...


13 Nov, 2018, 16:16 GMT Scientists from the Mérieux Foundation and the Child Health Research Foundation Warn of Potential Typhoid Crisis After Discovering New Highly Drug-Resistant Strains

Two new highly drug-resistant forms of Salmonella Typhi have been discovered in Bangladesh. The bacteria are responsible for typhoid fever, a...


13 Nov, 2018, 15:29 GMT First patient Enrolled in Pivotal Clinical Phase 3 Study NEFIGARD with Lead Candidate Nefecon

Calliditas Therapeutics AB (publ) ("Calliditas") today announced that the first patient has been enrolled in the company's pivotal clinical phase 3...


13 Nov, 2018, 10:20 GMT Liquid Handling Technology Market Size Worth $5.54 Billion by 2025: Grand View Research, Inc.

The global liquid handling technology market is expected to reach USD 5.54 billion by 2025, according to a new report by Grand View Research, Inc....


13 Nov, 2018, 09:00 GMT GammaDelta Therapeutics Announces Publication of New Data in Nature Immunology Describing the Independent Immune Function of Gamma Delta (γδ) T Cell Receptors

Findings support development of γδ T cells for gastrointestinal diseases GammaDelta Therapeutics Ltd, an emerging biotech company developing novel...


12 Nov, 2018, 16:55 GMT Diabeloop Obtains CE Marking for Its DBLG1™

The disruptive innovation for autonomous management of T1D Diabeloop announced today it has received the CE marking for the DBLG1™, its innovative...


12 Nov, 2018, 13:01 GMT CartiHeal Performs First Agili-C™ Implant Case on the East Coast

Surgery performed at NYU Langone Orthopedic Hospital in New York by sports medicine surgeon Eric Strauss, MD CartiHeal, developer of Agili-C, a...


12 Nov, 2018, 13:00 GMT CartiHeal Performs First Agili-C™ Implant Case on the East Coast

CartiHeal, developer of Agili-C, a proprietary implant for the treatment of joint surface lesions, announced today the successful enrollment of the...


12 Nov, 2018, 11:00 GMT Nyxoah Raises €15 Million in New Financing, Completes BLAST OSA Clinical Study

Nyxoah S.A., a medical device company focused on the development and commercialization of a best-in-class hypoglossal nerve stimulation (HGNS)...


09 Nov, 2018, 18:50 GMT Success of Hospital Pilot to Document Implants is First Step Leading to Data Analytics Used to Combat Dangers Stated in Netflix Documentary "The Bleeding Edge"

GS1 Ireland led an international coalition which successfully employed a sterile field scanner during surgery. The "TRACTUS" scanner by Matrix IT...


09 Nov, 2018, 05:16 GMT Alligator Bioscience and Aptevo Therapeutics Present New Preclinical Data for ALG.APV-527 at the Society for Immunotherapy of Cancer (SITC) 33rd Annual Meeting

Alligator Bioscience (Nasdaq Stockholm: ATORX), a biotechnology company developing antibody-based pharmaceuticals for tumor-directed immunotherapy,...


07 Nov, 2018, 13:00 GMT California research team publishes promising results from peptide based universal cancer vaccine

A team of researchers from the Dr. Rath Research Institute in California has developed a cancer vaccine effective in reducing tumor growth. This...


07 Nov, 2018, 12:30 GMT Endo Announces Positive Results from Phase 3 Studies of Collagenase Clostridium Histolyticum (CCH) in Patients with Cellulite

Endo International plc (NASDAQ: ENDP) announced positive results today from two identical Phase 3 RELEASE* studies of collagenase clostridium...


07 Nov, 2018, 08:00 GMT CartiHeal's Agili-C™ Implant Promotes the Regenerative Capacity of Articular Cartilage Defects in Human Cadaveric Ex-vivo Model

CartiHeal, developer of Agili-C™, a proprietary implant for the treatment of joint surface lesions, announced today the publication of a study...


06 Nov, 2018, 13:41 GMT BerGenBio Reports ~80% Improvement in PFS of AXL-positive vs AXL-negative NSCLC Patients in Bemcentinib + KEYTRUDA PhII Combination Trial

Late breaking abstract at SITC: Analysis of first stage of phase II trial with selective AXL inhibitor bemcentinib + KEYTRUDA in previously treated...


06 Nov, 2018, 13:01 GMT Alkermes Presents New Data on ALKS 4230 at Society for Immunotherapy of Cancer's (SITC) 33rd Annual Meeting

Alkermes plc (Nasdaq: ALKS) today announced the presentation of three abstracts at the Society for Immunotherapy of Cancer's (SITC) 33rd Annual...


06 Nov, 2018, 13:00 GMT OWC Pharmaceutical Research Corp. to Meet With Investors, Researchers and Business Partners at 2018 MJBizCon; Revealing the Testing of Novel Formulation for Multiple Myeloma Therapy

Subsequent to its recent announcement of the successful tests of its innovative delivery formulation aimed at Multiple Myeloma therapy, OWC...


06 Nov, 2018, 13:00 GMT OWC Pharmaceutical Research Corp. to Meet With Investors, Researchers and Business Partners at 2018 MJBizCon; Revealing the Testing of Novel Formulation for Multiple Myeloma Therapy

Subsequent to its recent announcement of the successful tests of its innovative delivery formulation aimed at Multiple Myeloma therapy, OWC...


06 Nov, 2018, 07:00 GMT PMD Solutions' Futuristic Wearable Respiratory Rate Monitoring Solution, RespiraSense, Earns Acclaim from Frost & Sullivan

Based on its recent analysis of the European non-invasive respiratory monitoring market, Frost & Sullivan recognises PMD Solutions with the 2018...


05 Nov, 2018, 11:00 GMT Veeda Clinical Research Successfully Completed its 5th WHO Audit

Veeda Clinical Research Pvt. Ltd., a leading independent CRO is proud to announce that our Shivalik, Insignia and Vedant (except bio analytical)...